日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery

一项随机III/IV期试验的结果比较了在接受大型骨科手术的重度或中度重度A型血友病成人患者中，间歇性推注与持续输注抗血友病因子（重组）的疗效。

期刊:Haemophilia
影响因子:3
doi:10.1111/hae.14219
Pabinger, Ingrid; Mamonov, Vasily; Windyga, Jerzy; Engl, Werner; Doralt, Jennifer; Tangada, Srilatha; Spotts, Gerald; Ewenstein, Bruce
发表日期：2021
文献求助 收藏

Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A

抗血友病因子（重组）溶于2 mL注射用无菌水中，用于治疗A型血友病患儿的上市后安全性监测研究

期刊:Haemophilia
影响因子:3
doi:10.1111/hae.13997
Motwani, Jayashree; Guillet, Benoit; Blatny, Jan; Schilling, Freimut H; Wibaut, Bénédicte; Goldstine, Jimena; Nagy, Andras; Doralt, Jennifer; Engl, Werner; Tangada, Srilatha; Spotts, Gerald
发表日期：2020
文献求助 收藏

Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects.

在健康受试者中，阿达木单抗生物类似药（M923）与阿达木单抗（Humira）具有药代动力学等效性、可比安全性和免疫原性

期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.380
Hillson Jan, Mant Tim, Rosano Molly, Huntenburg Carolyn, Alai-Safar Mehrshid, Darne Siddhesh, Palmer Donna, Pavlova Borislava G, Doralt Jennifer, Reeve Russell, Goel Niti, Weilert Doris, Rhyne Paul W, Chance Kamali, Caminis John, Roach James, Ganguly Tanmoy
其它
发表日期：2018
文献求助 收藏

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

重组ADAMTS-13：在先天性血栓性血小板减少性紫癜患者中的首次人体药代动力学和安全性研究

期刊:Blood
影响因子:23.1
doi:10.1182/blood-2017-06-788026
Scully, Marie; Knöbl, Paul; Kentouche, Karim; Rice, Lawrence; Windyga, Jerzy; Schneppenheim, Reinhard; Kremer Hovinga, Johanna A; Kajiwara, Michiko; Fujimura, Yoshihiro; Maggiore, Caterina; Doralt, Jennifer; Hibbard, Christopher; Martell, Leah; Ewenstein, Bruce
心血管
血小板
ADAMTS-1
ADA
发表日期：2017
文献求助 收藏

Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease

一项针对阿尔茨海默病老年患者的长期安慰剂对照研究证实了静脉注射免疫球蛋白的安全性

期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1016/j.trci.2016.06.003
Gelmont, David; Thomas, Ronald G; Britt, Jonathan; Dyck-Jones, Jacqueline A; Doralt, Jennifer; Fritsch, Sandor; Brewer, James B; Rissman, Robert A; Aisen, Paul
阿尔茨海默症
免疫/内分泌
发表日期：2016
文献求助 收藏

Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate)

全球上市后安全性监测研究：使用 FEIBA（一种活化凝血酶原复合物浓缩物）进行预防和按需治疗的真实世界数据

期刊:Blood Coagulation & Fibrinolysis
影响因子:1.1
doi:10.1097/MBC.0000000000000525
Negrier, Claude; Voisin, Sophie; Baghaei, Fariba; Numerof, Robert; Novack, Aaron; Doralt, Jennifer E; Romanov, Vadim; Gringeri, Alessandro
发表日期：2016
文献求助 收藏